levothyroxine sodium

Generic: levothyroxine sodium

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name levothyroxine sodium
Generic Name levothyroxine sodium
Labeler bryant ranch prepack
Dosage Form TABLET
Routes
ORAL
Active Ingredients

levothyroxine sodium 25 ug/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-1625
Product ID 71335-1625_b683d3b0-17cc-41a0-8aa5-7e01b11fe05b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021342
Listing Expiration 2026-12-31
Marketing Start 2020-08-03

Pharmacologic Class

Classes
thyroxine [cs] l-thyroxine [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713351625
Hyphenated Format 71335-1625

Supplemental Identifiers

RxCUI
966220
UNII
9J765S329G

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levothyroxine sodium (source: ndc)
Generic Name levothyroxine sodium (source: ndc)
Application Number NDA021342 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 ug/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (71335-1625-1)
  • 90 TABLET in 1 BOTTLE (71335-1625-2)
  • 100 TABLET in 1 BOTTLE (71335-1625-3)
  • 60 TABLET in 1 BOTTLE (71335-1625-4)
  • 28 TABLET in 1 BOTTLE (71335-1625-5)
  • 10 TABLET in 1 BOTTLE (71335-1625-6)
source: ndc

Packages (6)

71335-1625-1 30 TABLET in 1 BOTTLE (71335-1625-1) 71335-1625-2 90 TABLET in 1 BOTTLE (71335-1625-2) 71335-1625-3 100 TABLET in 1 BOTTLE (71335-1625-3) 71335-1625-4 60 TABLET in 1 BOTTLE (71335-1625-4) 71335-1625-5 28 TABLET in 1 BOTTLE (71335-1625-5) 71335-1625-6 10 TABLET in 1 BOTTLE (71335-1625-6)

Ingredients (1)

levothyroxine sodium (25 ug/1)

Linked Drug Pages (1)

Levothyroxine Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b683d3b0-17cc-41a0-8aa5-7e01b11fe05b", "openfda": {"unii": ["9J765S329G"], "rxcui": ["966220"], "spl_set_id": ["2883127f-0a2f-492d-a6cb-27ee14de0932"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1625-1)", "package_ndc": "71335-1625-1", "marketing_start_date": "20240403"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-1625-2)", "package_ndc": "71335-1625-2", "marketing_start_date": "20240403"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (71335-1625-3)", "package_ndc": "71335-1625-3", "marketing_start_date": "20240403"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-1625-4)", "package_ndc": "71335-1625-4", "marketing_start_date": "20240403"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (71335-1625-5)", "package_ndc": "71335-1625-5", "marketing_start_date": "20240403"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1625-6)", "package_ndc": "71335-1625-6", "marketing_start_date": "20240403"}], "brand_name": "Levothyroxine Sodium", "product_id": "71335-1625_b683d3b0-17cc-41a0-8aa5-7e01b11fe05b", "dosage_form": "TABLET", "pharm_class": ["Thyroxine [CS]", "l-Thyroxine [EPC]"], "product_ndc": "71335-1625", "generic_name": "Levothyroxine Sodium", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levothyroxine Sodium", "active_ingredients": [{"name": "LEVOTHYROXINE SODIUM", "strength": "25 ug/1"}], "application_number": "NDA021342", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20200803", "listing_expiration_date": "20261231"}